期刊文献+

活血养阴剂对2型糖尿病肾病患者血清Ⅳ型胶原及尿微量蛋白的影响 被引量:4

下载PDF
导出
摘要 目的:观察活血养阴剂对2型糖尿病肾病Ⅲ期、Ⅳ期患者血清Ⅳ型胶原及尿微量蛋白的影响。方法:选择2型糖尿病肾病分期诊断符合Mogensen标准Ⅲ期早期肾病、Ⅳ期临床肾病患者60例,随机分为2组,对照组30例予控制饮食,控制血糖、血压,控制感染,纠正酸中毒及电解质紊乱,纠正血脂紊乱等对症治疗,治疗组30例在对照组治疗的基础上加服活血养阴剂,连续治疗3个月,观察治疗前后患者血清Ⅳ型胶原及尿微量蛋白的变化。结果:治疗组对照组治疗后较治疗前血清Ⅳ型胶原及尿微量蛋白均有下降,治疗组治疗后较对照组治疗后下降更为显著(P<0.05),差异有显著性意义。结论:活血养阴剂能减少蛋白尿,抑制血清Ⅳ型胶原的表达,从而延缓糖尿病肾病的进展。
出处 《陕西中医》 2011年第4期414-415,共2页 Shaanxi Journal of Traditional Chinese Medicine
  • 相关文献

参考文献4

  • 1kuhn k. Basement membrane (type IV ) collagen[J]. Matrix Boil, 1995, 14(6).. 439-445.
  • 2Lee IK, Park KY, Oh HK, et aI. Piasma type IV collagen and fibronection concentrations in diabetic patients with microangiopathy[J]. J Korean Med Sci, 1994, 9(4):341- 346.
  • 3Meyer IJ, Szukics B, Neubauer K, et al. Extracellular matrix proteins as early markers in diabetic nephropathy[J]. Eur J Clin Biochem, 1995, 33(4):211-219.
  • 4罗飞宏.糖尿病肾病早期检测标志物研究新进展[J].国外医学(儿科学分册),2003,30(1):7-10. 被引量:32

二级参考文献16

  • 1Rossing P, Rossing K, Jacobsen P, et al. Unchanged incidence of diabetes nephropathy in IDDM patients[J]. Diabetes, 1995,44(7): 739-743.
  • 2Fioretto P, Steffes MW, Mauer M. Glomemlar structure in nonproteinuric IDDM patients with various levels of albuminuria[J].Diabetes, 1994,43(11):1358-1364.
  • 3Yamazaki M, Ito S, Usami A, et al. Urinary excretion rate of ceruloplasmin in non-insulin-dependent diabetic patients with different stages of nephropathy[J]. Eur J Endocrinol, 1995,132(6):681-687.
  • 4Narita T, Fujita H, Koshimura J, et al. Glycemic control reverses increase in urinary excretions of immunoglobulin G and ceruloplasmin in type 2 diabetic patients with normoalbuminuria[J]. Horm Metab Res, 2001,33(6):370-378.
  • 5Torffvit O, Rippe B. Size and charge selectivity of the glomerular filter in patients with insulin-dependent diatetes mellitus: urinary immunoglobulins and glycosaminoglycans[J]. Nephron, 1999,83(4):301 -307.
  • 6Kanauchi M, Akai Y, Hashimoto T. Transferrinuria in type 2 diabetic patients with early nephropathy and tubulointerstitial injury[J]. Eur J Intern Med, 2002,13(3):190-193.
  • 7Kotajima N, Fukumura Y, Obata K, et al. The significance of determination of urinary type Ⅳ collagen concentrations from a random urine collection in patients with non-insulin-dependent diabetes mellitus[J]. Rinsho Byori, 1998,46(3):277-282.
  • 8lijima T, Suzuki S, Sekizuka K, et al. Follow-up study on urinary type Ⅳ collagen in patients with early stage diabetic nephropathy[J]. J Clin Lab Anal, 1998,12(6):378-382.
  • 9Watanabe H, Sanada H, Shigetomi S, et al. Urinary excretion of type Ⅳ collagen as a specific indicator of the progression of diabetic nephropathy[J]. Nephron, 2000,86(1):27-35.
  • 10Masmiquel L, Segura RM, Mateo C, et al. Serum laminin as a marker of diabetic retinopathy development: a 4-year follow-up study[J].Am J Ophthalmol, 2002,129(3):347-352.

共引文献31

同被引文献71

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部